Q3 results on Feb 08, 2016
Piramal Enterprises Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 08, 2016, to consider and approve the Unaudited Financial Results (consolidated and standalone) of the Company for the quarter and nine months ended December 31, 2015 (Q3).In this regard, the Trading Window for dealing in the securities of the Company will remain closed from February 02, 2016 to February 10, 2016 (both... Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
The Sri Krishna Trust has submitted the disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Sri Krishna Trust has submitted the disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Piramal Enterprises Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Outcome of Committee Meeting
Piramal Enterprises Ltd has informed BSE that at the Meeting of Committee of Directors (Funding) held on January 13, 2016, the Committee approved the allotment of 5,000 Secured Redeemable Non-Convertible Debentures (NCDs), having the Face Value of Rs. 10,00,000/- (Rs. Ten Lakh only) each, aggregating to Rs. 500 Crores. These NCDs shall be listed on the National Stock Exchange of India Limited -Wholesale Debt Segment. Piramal Enterprises announces sale of its Canada-based cartilage repair product, BST-CarGel to Smith & Nephew
Piramal Enterprises Ltd has informed BSE regarding a Press Release dated January 12, 2016 titled "Piramal Enterprises announces sale of its Canada-based cartilage repair product, BST-CarGel to Smith & Nephew". Piramal sells cartilage-repair product to Smith & Nephew
Piramal Enterprises Ltd has sold BST-CarGel, its cartilage repair product, to med-tech company Smith & Nephew, for an undisclosed sum. The sale was through Piramal Healthcare (Canada) Ltd, the ... Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Sri Krishna Trust has submitted the disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Aberdeen Asset Management Asia Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Piramal Enterprises gets director panel nod to raise up to Rs500 crore
The firm did not specify the purpose for the fund raising